TADV delivers ‘transformative advancement’ for no-option CLTI

A systemic review and meta-analysis found transcatheter arterialization of deep veins (TADV) produces higher rates of limb salvage, amputation-free survival (AFS), and wound healing than standard-of-care (SoC) in no-option chronic limb-threatening ischemia (CLTI) patients. The findings appear in the Journal…
TADV without venous branch coiling still yields strong limb salvage rates among ‘no-option’ CLTI patients

Transcatheter arterialization of deep veins (TADV) done without the coiling of venous outflow branches achieved sufficient distal perfusion after three months among “no-option” chronic limb-threatening ischemia (CLTI) patients, according to results from a study published in the Journal of Vascular…
Enduring PROMISE: Real-world outcomes study suggests results continue to flow from transcatheter arterialization of the deep veins

First retrospective analysis shows comparable outcomes data to those found in PROMISE II pivotal trial, authors report. The first post-approval multicenter analysis of so-called “no-option” chronic limb-threatening ischemia (CLTI) patients treated using a pioneering transcatheter arterialization of the deep veins…

